Tilray (NASDAQ:TLRY) Trading Down 0.2% – Should You Sell?

Tilray Inc (NASDAQ:TLRY)’s share price fell 0.2% during trading on Friday . The company traded as low as $0.85 and last traded at $0.87. 12,718,516 shares were traded during mid-day trading, a decline of 73% from the average session volume of 46,480,660 shares. The stock had previously closed at $0.87.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group lifted their price objective on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $2.70.

Tilray Stock Performance

The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.58 and a current ratio of 2.54. The firm has a market cap of $892.18 million, a P/E ratio of -3.17 and a beta of 2.07. The business’s 50-day simple moving average is $1.17 and its 200 day simple moving average is $1.46.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities analysts predict that Tilray Inc will post -0.2 earnings per share for the current year.

Institutional Investors Weigh In On Tilray

A number of large investors have recently made changes to their positions in TLRY. Ferguson Wellman Capital Management Inc. bought a new stake in Tilray during the third quarter valued at approximately $26,000. Lido Advisors LLC bought a new stake in shares of Tilray during the 4th quarter valued at $28,000. Verdence Capital Advisors LLC bought a new stake in shares of Tilray during the 4th quarter valued at $29,000. Dudley Capital Management LLC bought a new stake in shares of Tilray during the 4th quarter valued at $29,000. Finally, Ameritas Advisory Services LLC bought a new stake in shares of Tilray during the 4th quarter valued at $32,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.